Form 4: 23andMe Executive William G. Richards Reports Stock Disposal
SEC Form 4 Filing
William G. Richards, Head of Therapeutics Discovery at 23andMe, disposed of 57,365 shares of Class A Common Stock to cover tax obligations.
Summary
- On August 20, 2024, William G. Richards, Head of Therapeutics Discovery at 23andMe Holding Co., disposed of 57,365 shares of Class A Common Stock.
- The transaction was executed at a price of $0.3555 per share.
- Following the transaction, Richards directly owns 573,069 shares of Class A Common Stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to an insider stock transaction, which is neither inherently positive nor negative.
Industry Context
Form 4 filings are a routine part of regulatory compliance for company insiders and provide transparency into their transactions in the company's stock.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| 08/20/2024 | Date of transaction: William G. Richards disposed of shares. |
| 08/21/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.